Treace Medical price target lowered to $9.50 from $10 at Truist
Truist lowered the firm’s price target on Treace Medical (TMCI) to $9.50 from $10 and keeps a Hold rating on the shares after its recent ...
Truist Financial Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Treace Medical Concepts (TMCI – Research ...
John Treace Spends US$524k On Treace Medical Concepts Stock
Those following along with Treace Medical Concepts, Inc. (NASDAQ:TMCI) will no doubt be intrigued by the recent purchase of shares by John Treace, CEO, Founder & Director of the company, who spent a ...
Rhumbline Advisers Increases Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Rhumbline Advisers raised its stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 2.0% in the fourth quarter, according to the company in its most recent 13F filing with ...
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of “Hold” from Brokerages
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) has been given a consensus recommendation of “Hold” by the seven analysts that are covering the company, MarketBeat reports. Five ...